Región Metropolitana de Santiago
Este organismo compró $35.329.096.472 en 11.633 órdenes de compra , sobre todo en Medicamentos y productos farmacéuticos / Medicamentos anti infecciosos / Medicamentos antivirales y le compró principalmente a Sur Medical SpA.
238 meses con data · color por monto (sqrt scale)
| Año | Ene | Feb | Mar | Abr | May | Jun | Jul | Ago | Sep | Oct | Nov | Dic | Total año |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 |
| $1367,1 M |
| 2025 | $2402,7 M |
| 2024 | $2107,2 M |
| 2023 | $2816,8 M |
| 2022 | $1338 M |
| 2021 | $1018,6 M |
| 2020 | $888,8 M |
| 2019 | $901,2 M |
| 2018 | $1471,2 M |
| 2017 | $786,1 M |
| 2016 | $14,2 mil M |
| 2015 | $919,8 M |
| 2014 | $428,8 M |
| 2013 | $340,8 M |
| 2012 | $359,5 M |
| 2011 | $701,4 M |
| 2010 | $913,7 M |
| 2009 | $590,7 M |
| 2008 | $571,8 M |
| 2007 | $1180,7 M |
| 2006 | $34,7 M |
238 períodos con data
Fuente: Agregaciones mensuales sobre OCs ingeridas
10 contrapartes
Fuente: Tabla top_contrapartes_comprador
| Código | Fecha | Proveedor | Estado | Monto |
|---|---|---|---|---|
| 2980-226-AG26 | 15-05-2026 | Novartis Chile S.A. | Recepcion Conforme | $5.395.291 |
| 2980-236-AG26 | 15-05-2026 | Atencion Integral para el Enfermo Limitada | Aceptada | $446.250 |
| 2980-213-SE26 | 11-05-2026 | Logistica Empresarial SpA | Aceptada | $7.524.997 |
| 2980-214-AG26 | 11-05-2026 | Pfizer Chile S.A. | Recepcion Conforme | $5.000.349 |
| 2980-207-SE26 | 29-04-2026 | Fundacion Dr Jorge Perez Rifo | Recepcion Conforme | $11.174.133 |
| 2980-208-SE26 | 29-04-2026 | Fundacion Dr Jorge Perez Rifo | Recepcion Conforme | $15.760.995 |
| 2980-209-SE26 | 29-04-2026 | Fundacion Dr Jorge Perez Rifo | Recepcion Conforme | $10.713.977 |
| 2980-210-SE26 | 28-04-2026 | Fundacion Dr Jorge Perez Rifo | Recepcion Conforme | $2.063.327 |
| 2980-206-AG26 | 28-04-2026 | Pfizer Chile S.A. | Recepcion Conforme | $2.025.547 |
| 2980-205-AG26 | 28-04-2026 | Synthon Chile Limitada | Recepcion Conforme | $1.413.720 |
| 2980-212-SE26 | 27-04-2026 | Fundacion Dr Jorge Perez Rifo | Recepcion Conforme | $1.334.205 |
| 2980-211-SE26 | 27-04-2026 | Fundacion Dr Jorge Perez Rifo | Recepcion Conforme | $2.885.101 |
| 2980-202-AG26 | 22-04-2026 | Gador Limitada | Recepcion Conforme | $963.900 |
| 2980-203-AG26 | 22-04-2026 | Pfizer Chile S.A. | Recepcion Conforme | $5.000.349 |
| 2980-182-AG26 | 21-04-2026 | Johnson y Johnson de Chile S.A. | Recepcion Conforme | $667.590 |
| 2980-188-AG26 | 21-04-2026 | Comercializadora de Alimentos Especializados, Medicamentos y Dispositivos Medico | Aceptada | $2.513.280 |
| 2980-186-AG26 | 21-04-2026 | Novofarma Service S.A. | Recepcion Conforme | $3.570.071 |
| 2980-193-AG26 | 21-04-2026 | Dr. Reddys Laboratories Chile SpA | Recepcion Conforme | $963.900 |
| 2980-179-AG26 | 21-04-2026 | Scienza Chile SpA | Recepcion Conforme | $5.414.500 |
| 2980-195-AG26 | 21-04-2026 | Askeny Chile SpA | Recepcion Conforme | $599.760 |
| 2980-192-AG26 | 21-04-2026 | Novartis Chile S.A. | Recepcion Conforme | $4.797.380 |
| 2980-198-AG26 | 21-04-2026 | Astrazeneca S.A. | Recepcion Conforme | $1.897.762 |
| 2980-184-AG26 | 21-04-2026 | Varifarma Chile SpA | Recepcion Conforme | $1.857.114 |
| 2980-197-AG26 | 21-04-2026 | Novartis Chile S.A. | Recepcion Conforme | $3.198.254 |
| 2980-190-AG26 | 21-04-2026 | Novofarma Service S.A. | Recepcion Conforme | $2.627.320 |
| 2980-196-AG26 | 21-04-2026 | Merck Sharp & Dohme (I.a) Llc,agencia en Chile | Recepcion Conforme | $386.096 |
| 2980-181-AG26 | 21-04-2026 | Gador Limitada | Recepcion Conforme | $4.522.000 |
| 2980-187-AG26 | 21-04-2026 | Glaxosmithkline Chile Farmaceutica Limitada | Recepcion Conforme | $2.447.663 |
| 2980-189-AG26 | 21-04-2026 | Laboratorios Kampar S.A. | Recepcion Conforme | $2.380.000 |
| 2980-180-AG26 | 21-04-2026 | Abbvie Productos Farmaceuticos Limitada | Recepcion Conforme | $2.445.272 |
